Free Trial

MarketBeat Instant News Alerts

lululemon athletica logo with Consumer Discretionary background

lululemon athletica (NASDAQ:LULU) Issues Q2 2026 Earnings Guidance

lululemon athletica (NASDAQ:LULU) updated its second quarter 2026 earnings guidance. The company provided EPS guidance of 1.760-1.810 for the period, compared to the consensus estimate of 2.690. The company also issued revenue guidance of $2.5 billionillion-$2.5 billionillion, compared to the consensus estimate of $2.6 billionillion.

NASDAQ:LULU
Read lululemon athletica (NASDAQ:LULU) Issues Q2 2026 Earnings Guidance
lululemon athletica logo with Consumer Discretionary background

lululemon athletica (NASDAQ:LULU) Releases FY 2026 Earnings Guidance

lululemon athletica (NASDAQ:LULU) updated its FY 2026 earnings guidance. The company provided EPS guidance of 10.950-11.150 for the period, compared to the consensus estimate of 12.350. The company also issued revenue guidance of $11.0 billionillion-$11.2 billionillion, compared to the consensus estimate of $11.5 billionillion.

NASDAQ:LULU
Read lululemon athletica (NASDAQ:LULU) Releases FY 2026 Earnings Guidance
Rubrik logo with Computer and Technology background

Rubrik (NYSE:RBRK) Updates Q2 2027 Earnings Guidance

Rubrik (NYSE:RBRK) updated its second quarter 2027 earnings guidance. The company provided EPS guidance of 0.030-0.050 for the period, compared to the consensus estimate of -0.070. The company also issued revenue guidance of $395.0 millionillion-$397.0 millionillion, compared to the consensus estimate of $382.6 millionillion.

NYSE:RBRK
Read Rubrik (NYSE:RBRK) Updates Q2 2027 Earnings Guidance
Rubrik logo with Computer and Technology background

Rubrik (NYSE:RBRK) Releases FY 2027 Earnings Guidance

Rubrik (NYSE:RBRK) updated its FY 2027 earnings guidance. The company provided EPS guidance of 0.250-0.350 for the period, compared to the consensus estimate of -0.150. The company also issued revenue guidance of $1.6 billionillion-$1.6 billionillion, compared to the consensus estimate of $1.6 billionillion.

NYSE:RBRK
Read Rubrik (NYSE:RBRK) Releases FY 2027 Earnings Guidance
NextEra Energy logo with Utilities background

Traders Purchase High Volume of NextEra Energy Call Options (NYSE:NEE)

NextEra Energy, Inc. (NYSE:NEE - Get Free Report) was the recipient of some unusual options trading on Thursday. Stock investors bought 177,348 call options on the company. This is an increase of 843% compared to the average volume of 18,801 call options.

NYSE:NEE
Read Traders Purchase High Volume of NextEra Energy Call Options (NYSE:NEE)
Bank of America logo with Finance background

Traders Purchase Large Volume of Bank of America Call Options (NYSE:BAC)

Bank of America Corporation (NYSE:BAC) was the recipient of some unusual options trading on Thursday. Stock traders purchased 486,148 call options on the company. This is an increase of approximately 222% compared to the average volume of 151,166 call options.

NYSE:BAC
Read Traders Purchase Large Volume of Bank of America Call Options (NYSE:BAC)

Trending News

All MarketBeat Instant News Alerts

Thor Industries logo with Auto/Tires/Trucks background

Thor Industries (NYSE:THO) Shares Down 5.6% After Earnings Miss

NYSE:THO
Read Thor Industries (NYSE:THO) Shares Down 5.6% After Earnings Miss
Kaltura logo with Computer and Technology background

Kaltura (NASDAQ:KLTR) Insider Sells $25,279.12 in Stock

NASDAQ:KLTR
Read Kaltura (NASDAQ:KLTR) Insider Sells $25,279.12 in Stock
Finning International logo with Industrials background

Insider Selling: Finning International (TSE:FTT) Insider Sells 1,478 Shares of Stock

TSE:FTT
Read Insider Selling: Finning International (TSE:FTT) Insider Sells 1,478 Shares of Stock
Applied Optoelectronics logo with Computer and Technology background

Applied Optoelectronics (NASDAQ:AAOI) Trading Up 10.6% - Should You Buy?

NASDAQ:AAOI
Read Applied Optoelectronics (NASDAQ:AAOI) Trading Up 10.6% - Should You Buy?
Aclaris Therapeutics logo with Medical background

Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052

NASDAQ:ACRS
Read Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052
The Descartes Systems Group logo with Computer and Technology background

Canadian Imperial Bank of Commerce Boosts The Descartes Systems Group (NASDAQ:DSGX) Price Target to $118.00

NASDAQ:DSGX
Read Canadian Imperial Bank of Commerce Boosts The Descartes Systems Group (NASDAQ:DSGX) Price Target to $118.00
The Descartes Systems Group logo with Computer and Technology background

The Descartes Systems Group (NASDAQ:DSGX) Price Target Lowered to $108.00 at Raymond James Financial

NASDAQ:DSGX
Read The Descartes Systems Group (NASDAQ:DSGX) Price Target Lowered to $108.00 at Raymond James Financial
Reddit logo with Computer and Technology background

Traders Buy Large Volume of Call Options on Reddit (NYSE:RDDT)

NYSE:RDDT
Read Traders Buy Large Volume of Call Options on Reddit (NYSE:RDDT)
Applied Optoelectronics logo with Computer and Technology background

Applied Optoelectronics Sees Unusually High Options Volume (NASDAQ:AAOI)

NASDAQ:AAOI
Read Applied Optoelectronics Sees Unusually High Options Volume (NASDAQ:AAOI)
AT&T logo with Computer and Technology background

AT&T Target of Unusually High Options Trading (NYSE:T)

NYSE:T
Read AT&T Target of Unusually High Options Trading (NYSE:T)
Petco Health and Wellness logo with Retail/Wholesale background

Citigroup Lowers Petco Health and Wellness (NASDAQ:WOOF) Price Target to $3.25

NASDAQ:WOOF
Read Citigroup Lowers Petco Health and Wellness (NASDAQ:WOOF) Price Target to $3.25
Sprinklr logo with Business Services background

Citigroup Issues Pessimistic Forecast for Sprinklr (NYSE:CXM) Stock Price

NYSE:CXM
Read Citigroup Issues Pessimistic Forecast for Sprinklr (NYSE:CXM) Stock Price
Tempus AI logo with Medical background

Tempus AI (NASDAQ:TEM) Trading Up 9.3% - Time to Buy?

NASDAQ:TEM
Read Tempus AI (NASDAQ:TEM) Trading Up 9.3% - Time to Buy?
10x Genomics logo with Medical background

10x Genomics (NASDAQ:TXG) Stock Price Up 9.5% - Should You Buy?

NASDAQ:TXG
Read 10x Genomics (NASDAQ:TXG) Stock Price Up 9.5% - Should You Buy?
Beam Therapeutics logo with Medical background

Beam Therapeutics (NASDAQ:BEAM) Trading 10.1% Higher - What's Next?

NASDAQ:BEAM
Read Beam Therapeutics (NASDAQ:BEAM) Trading 10.1% Higher - What's Next?
Recursion Pharmaceuticals logo with Medical background

Recursion Pharmaceuticals (NASDAQ:RXRX) Trading 12.5% Higher - Here's What Happened

NASDAQ:RXRX
Read Recursion Pharmaceuticals (NASDAQ:RXRX) Trading 12.5% Higher - Here's What Happened
Celcuity logo with Medical background

Celcuity (NASDAQ:CELC) Sees Strong Trading Volume - Should You Buy?

NASDAQ:CELC
Read Celcuity (NASDAQ:CELC) Sees Strong Trading Volume - Should You Buy?
Broadcom logo with Computer and Technology background

Mizuho Issues Positive Forecast for Broadcom (NASDAQ:AVGO) Stock Price

NASDAQ:AVGO
Read Mizuho Issues Positive Forecast for Broadcom (NASDAQ:AVGO) Stock Price
Broadcom logo with Computer and Technology background

Broadcom (NASDAQ:AVGO) Given New $530.00 Price Target at Bank of America

NASDAQ:AVGO
Read Broadcom (NASDAQ:AVGO) Given New $530.00 Price Target at Bank of America
Veeva Systems logo with Medical background

Citigroup Issues Positive Forecast for Veeva Systems (NYSE:VEEV) Stock Price

NYSE:VEEV
Read Citigroup Issues Positive Forecast for Veeva Systems (NYSE:VEEV) Stock Price
Hyatt Hotels logo with Consumer Discretionary background

Hyatt Hotels (NYSE:H) Raised to "Buy" at HSBC

NYSE:H
Read Hyatt Hotels (NYSE:H) Raised to "Buy" at HSBC
Adicet Bio logo with Medical background

Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference

NASDAQ:ACET
Read Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference
Vicor logo with Computer and Technology background

Vicor (NASDAQ:VICR) Stock Price Down 6.3% Following Insider Selling

NASDAQ:VICR
Read Vicor (NASDAQ:VICR) Stock Price Down 6.3% Following Insider Selling
Shake Shack logo with Retail/Wholesale background

Shake Shack (NYSE:SHAK) Given New $77.00 Price Target at BNP Paribas Exane

NYSE:SHAK
Read Shake Shack (NYSE:SHAK) Given New $77.00 Price Target at BNP Paribas Exane

Featured Articles and Offers

Alert Categories

All Alerts